2025-12-17 - Analysis Report
Here's a breakdown of the provided data and a comprehensive analysis of Salesforce (CRM):

**1) Return Rate Comparison**

*   **Company Overview:** Salesforce Inc. is a cloud-based software company specializing in customer relationship management (CRM).
*   **CRM Cumulative Return:** -5.95%
*   **VOO (S&P 500) Cumulative Return:** 99.81%
*   **Divergence:** Current divergence of -104.8 (Relative Divergence: 7.0) indicates a significant underperformance of CRM compared to the S&P 500 over the analyzed period. The relative divergence of 7.0 suggests that the current divergence is near the lowest end of its historical range.

**Alpha, Beta Analysis:**

*   **CAGR (Compound Annual Growth Rate):** Fluctuates significantly, ranging from -78% to 39% over different periods.
*   **MDD (Maximum Drawdown):** Consistently high, around 70-76%, indicating substantial risk.
*   **Alpha:**  Highly variable. Negative Alpha in recent periods (2018-2025) suggests underperformance relative to the market on a risk-adjusted basis. Positive Alpha in the earlier periods (2015-2018) indicates outperformance relative to the market on a risk-adjusted basis.
*   **Beta:** Varies between -2.1 and 0.7. Fluctuations in Beta values indicate the stock's varying sensitivity to market movements.
*   **Cap(B) (Market Capitalization):** Generally increasing over time, showing growth in company size.

**Analysis:** The data suggests that CRM's performance has become more volatile and less aligned with the market in recent years. High MDD values underscore the inherent risk associated with the stock.

**2) Stock Price Fluctuations**

*   **Current Close:** 254.91
*   **Last Market Data:** Price increased slightly (0.13) compared to the previous close.
*   **5-day SMA:** 259.654
*   **20-day SMA:** 244.1361
*   **60-day SMA:** 245.5237

**Analysis:** The 5-day SMA is above the 20-day and 60-day SMAs, suggesting a short-term upward trend. The price has recently broken above the 20-day and 60-day averages, indicating potential short-term bullish momentum.

**3) Index Indicators Analysis**

*   **MRI (Market Risk Indicator):** 0.7 (Medium Investment) suggests a moderate level of risk associated with the stock.
*   **RSI (Relative Strength Index):** 68.75 suggests the stock is approaching overbought territory.
*   **PPO (Percentage Price Oscillator):** 0.7128, indicates a positive trend, but not excessively so.
*   **Hybrid Signal:** "Buy 90% of cash" suggests a bullish signal based on the algorithm, considering the MRI.
*   **Recent Relative Divergence Change:** +4.8 (short-term increase) supports the short-term upward trend mentioned earlier.
*   **Expected Return:** -633.6% indicates a very negative long-term outlook based on the model's calculations.

**Analysis:** Mixed signals. The MRI and Hybrid signal suggest some bullish sentiment, but the high RSI hints at a potential pullback. The very negative expected return is a significant concern.

**4) Recent News & Significant Events**

*   **Salesforce (CRM) Stock After Hours Today (Dec. 15, 2025):** The stock fell due to concerns surrounding its AI thesis.
*   **Salesforce, Inc. (CRM) Expands Partnership With USDOT:** Positive news indicating expansion and collaboration.
*   **Salesforce (CRM) Stock News Today (Dec. 16, 2025):** Discusses Agentforce updates, dividend spotlight, analyst targets.
*   **Salesforce Stock (CRM) Slides on Dec. 15, 2025:** Wall Street remains bullish on Agentforce AI despite the slide.
*   **Salesforce Earnings Might Have Been Good Enough to End Its Stockâ€™s 3 Quarter Losing Streak:** Positive sentiment regarding earnings performance.
*   **Here's How Much Traders Expect Salesforce Stock to Move After Earnings Today:** Focuses on expected stock movement after earnings.

**Analysis:** The news is mixed. There's positive news about partnerships and potential earnings recovery. However, concerns exist regarding the AI thesis and the stock's recent slide.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean: 1.65)
*   **Target Price:** Average $330.06, High $475.00, Low $223.00.

**Analysis:** Analysts generally have a positive outlook on CRM, with a consensus "Buy" rating and a significant upside potential based on target prices. However, the wide range in target prices ($223 - $475) suggests uncertainty among analysts.

**5) Recent Earnings Analysis**

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2025-12-04 | 2.2  | 10.26 B$    |
| 2025-09-04 | 1.97 | 10.24 B$    |
| 2025-05-29 | 1.61 | 9.83 B$     |
| 2024-12-04 | 1.6  | 9.44 B$     |
| 2025-12-04 | 1.6  | 9.44 B$     |

**Analysis:**  Earnings per share (EPS) and revenue have generally been increasing, suggesting positive growth in the company's financial performance. 2025-12-04 data is likely a duplicate of 2024-12-04 and shouldn't be used.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue     | Profit Margin |
|--------------|-------------|---------------|
| 2025-10-31   | $10.26B     | 78.02%        |
| 2025-07-31   | $10.24B     | 78.10%        |
| 2025-04-30   | $9.83B      | 76.96%        |
| 2025-01-31   | $9.99B      | 77.81%        |
| 2024-10-31   | $9.44B      | 77.71%        |

**Capital and Profitability:**

| Quarter      | Equity      | ROE    |
|--------------|-------------|--------|
| 2025-10-31   | $60.02B     | 3.48%  |
| 2025-07-31   | $61.33B     | 3.08%  |
| 2025-04-30   | $60.67B     | 2.54%  |
| 2025-01-31   | $61.17B     | 2.79%  |
| 2024-10-31   | $58.52B     | 2.61%  |

**Analysis:** Revenue has been steadily increasing, and profit margins are consistently high, indicating strong financial performance. Equity is relatively stable. ROE (Return on Equity) has fluctuated, with the most recent quarter showing the highest value in the dataset, which is a positive sign.

**7) Comprehensive Analysis**

*   **Performance Divergence:** CRM has significantly underperformed the S&P 500 (VOO) over the past several years.
*   **Volatility and Risk:** CRM exhibits high volatility and risk, as evidenced by its high Maximum Drawdown (MDD).
*   **Mixed Signals:** There are mixed signals from the indicators. Short-term indicators suggest a slight upward trend, but the long-term expected return is highly negative.
*   **Analyst Optimism:** Analysts generally have a positive outlook, but target prices vary significantly, indicating uncertainty.
*   **Positive Financial Growth:** Recent earnings and financial data show positive revenue growth and high profit margins. ROE is also trending upwards.
*   **News Impact:** News articles reveal a mix of positive developments (partnerships, earnings potential) and concerns (AI thesis).

**Conclusion:**

CRM presents a complex investment picture. While recent financial performance and analyst sentiment are positive, the stock has significantly underperformed the market and exhibits high volatility.  The extremely negative expected return and the recent stock price decline related to AI concerns should be carefully considered. Investors should weigh the potential for future growth against the inherent risks and market underperformance before making an investment decision. The conflicting signals suggest a cautious approach is warranted.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.